Table 1 Baseline characteristics of the cohort.
From: HCC risk stratification scores: insights from large multi-center national cohort study
Variable | NCCVH Cohort |
|---|---|
Patient number | 8558 |
Age (years) | 60.0 (53.0–67.0) |
Sex | |
Males | 3724 (43.5) |
Females | 4834 (56.5) |
ALT (U/L) | 42.0 (23.0–65.0) |
AST (U/L) | 45.0 (30.0–65.0) |
Total Bilirubin (mg/dL) | 0.90 (0.70–1.30) |
Albumin (g/dL) | 3.9 (3.5–4.2) |
Platelets count (/cmm3) | 150.0 (122.0–185.0) |
AFP (ng/ml) | 3.48 (2.30–5.40) |
Comorbidities | |
Yes | 576 (6.7%) |
No | 7982 (93.3%) |
FIB4 | 2.84 (1.81–4.02) |
Follow up duration (months, mean ± SD) | 25.79 ± 12.90 |
